These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


573 related items for PubMed ID: 12746659

  • 21. [Clinical and morphological characteristics of lupus nephritis in systemic lupus erythematosus with antiphospholipid syndrome].
    Kozlovskaia NL, Shilov EM, Meteleva NA, Varshavskiĭ VA, Miroshnichenko NG, Samokishina NA, Serova AG, Nesterova SG.
    Ter Arkh; 2006; 78(5):21-31. PubMed ID: 16889045
    [Abstract] [Full Text] [Related]

  • 22. Histological features of antiphospholipid nephropathy in patients with Systemic Lupus Erythematosus.
    Naseeb F, Arfaj AA, Hamdani A, Kfoury H, Parvez K, Mogairen SA.
    J Coll Physicians Surg Pak; 2015 May; 25(5):332-6. PubMed ID: 26008657
    [Abstract] [Full Text] [Related]

  • 23. [Systemic lupus erythematosus and antiphospholipid syndrome].
    Gröne HJ.
    Verh Dtsch Ges Pathol; 1996 May; 80():21-37. PubMed ID: 9065004
    [Abstract] [Full Text] [Related]

  • 24. [Immunopathology of the antiphospholipid syndrome].
    Stojanović Lj, Alekbergova Z, Kalasnikova Lj, Nasonov E, Manujlova L, Sokolov V, Stanić M.
    Srp Arh Celok Lek; 1994 May; 122 Suppl 1():53-6. PubMed ID: 18173188
    [Abstract] [Full Text] [Related]

  • 25. [Vasculopathy in patients with systemic lupus erythematosus and the antiphospholipid syndrome].
    Alekberova ZS, Reshetniak TM, Rodenska-Lopovok SG, Aleksandrova EN, Kalashnikova LA, Nasonov EL, Mach ES, Nasonova VA.
    Ter Arkh; 1995 May; 67(5):41-4. PubMed ID: 7638777
    [Abstract] [Full Text] [Related]

  • 26. [Clinicomorphological features of nephropathy in primary and secondary antiphospholipid syndrome].
    Kozlovskaia NL, Shilov EM, Meteleva NA, Varshavskiĭ VA, Kushnir VV, Shakhnova EA, Miroshnichenko NG, Serova AG, Nesterova SG.
    Ter Arkh; 2007 May; 79(6):16-25. PubMed ID: 17684961
    [Abstract] [Full Text] [Related]

  • 27. The intrarenal vascular lesions associated with primary antiphospholipid syndrome.
    Nochy D, Daugas E, Droz D, Beaufils H, Grünfeld JP, Piette JC, Bariety J, Hill G.
    J Am Soc Nephrol; 1999 Mar; 10(3):507-18. PubMed ID: 10073601
    [Abstract] [Full Text] [Related]

  • 28. Anti-oxLDL antibodies--marker for arterial thromboses in antiphospholipid syndrome?
    Bećarevic M, Andrejević S, Bonaci-Nikolić B, Obradović I, Miljić P, Majkić-Singh N.
    Clin Lab; 2005 Mar; 51(5-6):279-83. PubMed ID: 15991801
    [Abstract] [Full Text] [Related]

  • 29. Zonal cortical scarring and tubular thyroidization in kidney biopsies of patients with SLE-histologic indicator for antiphospholipid antibodies.
    Shah R, Brodsky SV, Hebert L, Rovin BH, Nadasdy T, Satoskar AA.
    Lupus; 2018 Dec; 27(14):2236-2244. PubMed ID: 30403144
    [Abstract] [Full Text] [Related]

  • 30. Antiphospholipid syndrome and systemic lupus erythematosus: are they separate entities or just clinical presentations on the same scale?
    Shoenfeld Y, Meroni PL, Toubi E.
    Curr Opin Rheumatol; 2009 Sep; 21(5):495-500. PubMed ID: 19593144
    [Abstract] [Full Text] [Related]

  • 31. [Antiphospholipid antibodies and antiphospholipid syndrome in juvenile lupus erythematosus].
    Romicka AM, Gazda A, Zabek J, Wojciechowska B.
    Pol Arch Med Wewn; 2006 May; 115(5):477-80. PubMed ID: 17195365
    [No Abstract] [Full Text] [Related]

  • 32. IgM anti-β2 glycoprotein I is protective against lupus nephritis and renal damage in systemic lupus erythematosus.
    Mehrani T, Petri M.
    J Rheumatol; 2011 Mar; 38(3):450-3. PubMed ID: 21123325
    [Abstract] [Full Text] [Related]

  • 33. [Antiphospholipid syndrome and kidney].
    Roccatello D, Rossi D, Giachino O, Bazzan M, Mazzucco G.
    G Ital Nefrol; 2007 Mar; 24(2):111-20. PubMed ID: 17458826
    [Abstract] [Full Text] [Related]

  • 34. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
    Moore GW, Rangarajan S, Savidge GF.
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
    [Abstract] [Full Text] [Related]

  • 35. Anti-beta 2-glycoprotein I and antiphosphatidylserine antibodies are predictors of arterial thrombosis in patients with antiphospholipid syndrome.
    Lopez LR, Dier KJ, Lopez D, Merrill JT, Fink CA.
    Am J Clin Pathol; 2004 Jan; 121(1):142-9. PubMed ID: 14750252
    [Abstract] [Full Text] [Related]

  • 36. [Antiendothelial antibodies in systemic lupus erythematosus in men: the connection with kidney involvement and the antiphospholipid syndrome].
    Nasonov EL, Alekberova ZS, Salozhin KV, Kliukvina NG, Aleksandrova EN, Baranov AA, Le Tonqueze M, Youinou P.
    Ter Arkh; 1996 Jan; 68(6):46-9. PubMed ID: 8771685
    [No Abstract] [Full Text] [Related]

  • 37. [Retinal vascular lesions in systemic lupus erythematosus and secondary antiphospholipid syndrome].
    Ermakova NA, Alekberova ZS, Reshetniak TM, Kalashnikova LA, Kosheleva NM.
    Vestn Oftalmol; 2005 Jan; 121(5):31-6. PubMed ID: 16274063
    [Abstract] [Full Text] [Related]

  • 38. Antiphospholipid Syndrome Nephropathy: From Pathogenesis to Treatment.
    Tektonidou MG.
    Front Immunol; 2018 Jan; 9():1181. PubMed ID: 29904380
    [Abstract] [Full Text] [Related]

  • 39. Antiphospholipid antibody tests: spreading the net.
    Bertolaccini ML, Gomez S, Pareja JF, Theodoridou A, Sanna G, Hughes GR, Khamashta MA.
    Ann Rheum Dis; 2005 Nov; 64(11):1639-43. PubMed ID: 15817655
    [Abstract] [Full Text] [Related]

  • 40. Antiphospholipid syndrome nephropathy in antiphospholipid antibody-positive patients with systemic lupus erythematosus: comment on the article by Tektonidou et al.
    Korkmaz C.
    Arthritis Rheum; 2005 Mar; 52(3):988-9; author reply 989-90. PubMed ID: 15751054
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 29.